Related Experiment Video
Updated: Dec 25, 2025

The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability
Published on: April 28, 2022
Use of C-Reactive Protein and Ferritin Biomarkers in Daily Pediatric Practice
Matthew D Taylor1, Vivek Allada2, Michael L Moritz3
1Division of Critical Care Medicine, Cohen Children's Medical Center of New York, New Hyde Park, NY.
Insights
Pediatricians can use C-reactive protein (CRP) and ferritin biomarkers to assess inflammation. While useful in specific scenarios, further research is needed to standardize their application in clinical practice.
Area of Science:
- Pediatric Clinical Research
- Biomarker Analysis
- Inflammation Studies
Background:
- Multibiomarker models are increasingly used for risk stratification in pediatric clinical research.
- C-reactive protein (CRP) and ferritin are widely available biomarkers in pediatric practice.
- A comprehensive review of evidence supporting CRP and ferritin use in pediatrics is lacking.
Purpose of the Study:
- To summarize existing evidence on the use of CRP and ferritin biomarkers in pediatric practice.
- To initiate the development of a consensus for the future application of these biomarkers by pediatricians.
- To provide a single-source resource for clinicians regarding these inflammatory markers.
Main Methods:
- A systematic survey of all pediatric literature on CRP and ferritin available in PubMed was conducted.
- Research relevant to daily pediatric clinical practice was summarized.
- Contributions from pediatric subspecialists were integrated to describe biomarker use across various disease processes.
Main Results:
- CRP and ferritin biomarkers exhibit diverse applications and varied cutoff values in the literature, complicating daily clinical use.
- Elevated levels of CRP and ferritin correlate significantly with uncontrolled inflammation.
- A clinical decision pathway and summarized evidence are presented.
Conclusions:
- CRP and ferritin are widely utilized biomarkers in pediatrics.
- Sufficient evidence supports the utility of these inflammatory biomarkers in guiding clinical decisions in specific pediatric cases.
- Further research and standardization efforts are necessary to optimize the use of CRP and ferritin in routine pediatric clinical practice.
Abstract:
Recent pediatric clinical research has begun to focus on risk stratification tools using multibiomarker models. C-reactive protein (CRP) and ferriti biomarkers are widely available and used to varying degrees in daily practice, but there is no single source examining the evidence behind their use.We set out to summarize the evidence behind the use of CRP and ferritin biomarkers in pediatric practice and to begin development of a consensus for their future use for pediatricians.All the literature involving CRP and ferritin in pediatrics available on PubMed was surveyed. Research applicable to daily pediatric practice was summarized in the body of the article. Pediatric clinicians of various subspecialties contributed to the summary of the use of CRP and ferritin biomarkers in clinical practice in various disease processes. A clinical decision pathway is described, and evidence is summarized.CRP and ferritin biomarkers have diverse uses with various cutoff values in the literature, making their use in daily practice difficult. Elevation of these markers coincides with their significant elevation in uncontrolled inflammation.CRP and ferritin biomarkers are widely used in pediatrics. This review provides a resource summarizing evidence into a single source. There is sufficient evidence to indicate that these biomarkers of inflammation can be useful in guiding clinical decision making in specific clinical scenarios; however, further work is needed to improve their use in clinical practice.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
07:20Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics in Pediatric Patients: Drug Excretion